{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1116.397","meta":{"versionId":"4","lastUpdated":"2017-12-06T01:00:04.000-05:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.397","version":"20171206","name":"Patient receiving anti EGFR therapy","status":"active","date":"2017-12-06T01:00:04-05:00","publisher":"American Society of Clinical Oncology Steward","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","concept":[{"code":"G9839","display":"Anti-egfr monoclonal antibody therapy"}]}]},"expansion":{"identifier":"urn:uuid:ebfee3f9-ce6a-43d5-9d4b-17715bf2d94e","timestamp":"2022-06-10T10:48:03-04:00","total":1,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://www.nlm.nih.gov/research/umls/hcpcs","version":"2022","code":"G9839","display":"Anti-egfr monoclonal antibody therapy"}]}}